Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 3779 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed526    
    Printed27    
    Emailed0    
    PDF Downloaded77    
    Comments [Add]    

Recommend this journal

 
ARTICLE
Year : 2001  |  Volume : 43  |  Issue : 1  |  Page : 32-35

Once Daily Risperidone in Treatment of Schizophrenia


1 Senior Resident, Department of Psychiatry, Institute of Human Behaviour & Allied Sciences, P.O. Box 9520, Dilshad Garden, Delhi - 110 095, India
2 Additional Professor, Department of Psychiatry, Institute of Human Behaviour & Allied Sciences, P.O. Box 9520, Dilshad Garden, Delhi - 110 095, India

Correspondence Address:
Vivek Agarwal
Senior Resident, Department of Psychiatry, Institute of Human Behaviour & Allied Sciences, P.O. Box 9520, Dilshad Garden, Delhi - 110 095
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21407835

Rights and PermissionsRights and Permissions

Forty four schizophrenic patients were randomly assigned to receive risperidone in 4-8 mg doses either once daily or twice daily for 8 weeks. An open trial was conducted to determine the efficacy of once daily administration of risperidone as compared to twice daily administration. Assessment were done on Positive and Negative Syndrome Scale (PANSS) and Clinical Global Impression (CGI) scale Eighty two percent of the once daily patients and 79% of the twice daily patients showed a significant treatment response. No significant differences were observed between the two groups in response pattern and adverse effects at the end point. Risperidone given once daily was as effective as twice daily administration.



[PDF]*

        

Print this article         Email this article